CHUV Service de Néphrologie et d'Hypertension
Lausanne, 1011, Switzerland
Location status: Recruiting
NCT Number: NCT06698536
The present study, OBPM_COYOTE2024, with N = 255 participants minimum over 1 visit (lasting ~15min), has been designed to collect raw optical data with Aktiia.product-G2C Clinical investigational device together with Aktiia G2 Bracelet and Aktiia Init I1 oscillometric cuff within a cohort of subjects characterized by a wide variety of phenotypes. The resulting dataset will support research and development activities conducted by AKTIIA SA out of the study context.
Interested in participating?
Request Info21 year–85 year
All sexes
Interventional
Not applicable
Lausanne, 1011, Switzerland
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Study subjects are asked to stay seated while 3 successive measurements are taken with the Aktiia G2C device under investigation (BP and PR) and two references (Aktiia Bracelet G2 and Aktiia Init I1 oscillometric cuff).
Time frame: Baseline
Number of subjects including three assessments of blood pressure using Aktiia G2C Clinical, alongside three assessments of blood pressure with Aktiia Bracelet G2 and three values of blood pressure generated with the Aktiia Init I1 oscillometric cuff
Contact information is provided by the study sponsor or research team.
Aktiia SA
Industry
OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C Device at Fingertip and Wrist, Alongside the Aktiia Oscillometric Cuff: a Single-center, Prospective Clinical Study
Acronym: COYOTE2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07740434
Blood Pressure Monitoring, Ambulatory, Cardiovascular (CV) Risk
Chenôve, France
View Trial DetailsNCT07074145
Adherence Interventions, Behavior
Albuquerque, New Mexico, United States
View Trial DetailsNCT05962372
Abdominal Obesity, Body Weight
San Juan, Puerto Rico
View Trial DetailsNCT07728630
Cardiovascular Diseases, Endothelial Function
Osijek, Croatia
View Trial Details